Rapid response
Researchers are exploring the role of psychedelic drugs as a treatment for eating disorders. How are eating disorders currently treated and what does the latest research on psychedelic drugs show?
Rapid response
How is PTSD treated, how successful are current treatments and what is the potential role for psychedelic-assisted therapy?
Rapid response
The number of people voting in elections is an indicator of democratic health. In UK general elections, this number has declined since 1997. Why is this? What could be done to increase turnout?
Rapid response
How are anxiety disorders treated, how successful are current treatments and what is the potential role for psychedelic-assisted therapy?
Rapid response
Researchers are exploring the science of psychedelic drugs as a potential treatment for depression. How effective could they be, and what are the regulatory and legal challenges in their use?
Rapid response
What can deliberately infecting healthy people tell us about infectious diseases? How is this useful for developing treatments, and how do we manage the risks?
Rapid response
How do our bodies defend against Covid-19? Read how immune responses differ across people, variants, reinfection, vaccination, and current immunisation strategies.
Rapid response
A overview of science diplomacy, outlining its role in scientific collaborations and to support international diplomatic relationships, and a resume of recent developments.
Rapid response
Research studies involving thousands of people have allowed scientists to test which drugs are effective at treating COVID-19. Several drug therapies are now available to treat people who are in hospital with COVID-19, or to prevent infections in vulnerable people becoming more serious. This briefing explains which drugs are available, the groups of people in which they are used and how they work. It also outlines the importance of monitoring the emergence of new variants and drug resistance.
Rapid response
A new generation of COVID-19 vaccines could support vaccination strategies in the long term. But what are the latest developments from preclinical and clinical trials?
Rapid response
The Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been found across the world since it was first detected in early November 2021. This article describes the characteristics of the variant and its health impacts. It also discusses vaccine effectiveness against the variant and the medium and long-term outlook for the future course of the pandemic.
Rapid response
Immunisation strategies are one of the key elements to addressing the impacts of SARS-CoV-2 in the short- and long-term. What are the key factors to consider when developing long-term immunisation strategies? What are the key unknowns and how can they be addressed?
Rapid response
What is Long COVID ? How many people are affected? What are the key challenges for diagnosis and treatment? What are the priority areas for research?
Rapid response
The Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been found across the world since it was first detected in early November 2021. This article describes the characteristics of the variant, why scientists are concerned, and the possible impact that it might have on the course of the pandemic.
Rapid response
This rapid response presents current research on the impact of the pandemic on the ECEC sector in England and the impact of changes in access to ECEC on pre-school children.
Total results (page 3 of 8)